Ipca stock’s valuation seem reasonable relative to its earnings potential over the next few years. They trade at around 30 times its FY27 estimated earnings
3 min read9 Jun 2026Dividend Stocks 2025: Hyundai Motor, Alembic , IPCA , Chambal Fertilisers & Chemicals, DCM Shriram, Berger Paints, Jay Shree Tea & Industries and DCM Shriram are among 8 key stocks to trade ex dividend today, 5 August 2025
1 min read5 Aug 2025The stock market experienced a downturn with Sensex and Nifty 50 falling, influenced by foreign investor sell-offs and negative trends in Asia. Despite domestic buying, market sentiment remains cautious, and analysts suggest a bearish short-term outlook with critical support levels identified.
3 min read25 Jul 2025Pharma Stocks; The Indian pharma market experienced a robust growth of 9.3% year-on-year in March 2025, with key players like Cipla, Sun, Ipca Labs, and JB Pharma leading the charge. This marks a significant improvement compared to the previous year. Discover the driving factors behind this surge.
1 min read14 Apr 2025F&O Strategy: Technical views on F&O market by Rupak De, Senior Technical Analyst, LKP Securities. De suggests Balrampur Chini Mills Ltd, V-Guard Industries Ltd, and Ipca Laboratories Ltd.
3 min read1 Apr 2025Top Stock Recommendations: Osho Krishan, Sr. Analyst, Technical & Derivatives of Angel One, recommends buying Manali Petrochemical Ltd, and Ipca Laboratories Ltd.
2 min read11 Jul 2024Ipca Labs share price has been falling after disappointing quarterly results. Brokerage firms are divided, with some optimistic about margin improvement and new launches, while others urge caution due to the stock's recent high valuation.
3 min read31 May 2024Stocks in focus: Rajesh Palviya has recommended three stocks for Friday - IPCA Laboratories Ltd, Cyient Ltd, and Tech Mahindra Ltd.
4 min read5 Apr 2024Top Stock Recommendations: Osho Krishan, Sr. Analyst, Technical & Derivatives of Angel One, recommends buying Manali Petrochemical Ltd, and Ipca Laboratories Ltd.
2 min read11 Jul 2024Ipca Labs share price has been falling after disappointing quarterly results. Brokerage firms are divided, with some optimistic about margin improvement and new launches, while others urge caution due to the stock's recent high valuation.
3 min read31 May 2024Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.